AMD Pathology
The computed 12-month bankruptcy probability of AMD Pathology is 2.9% (moderate). The 2024 annual accounts show equity of €105k and a net result of €116k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €105k |
| Net result | €116k |
| Active | 3 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €148k |
| Net profit | €116k |
| Cash flow | €118k |
| Staff costs | - |
| Income taxes | €29k |
| Dividends | - |
| Total assets | €119k |
| Equity | €105k |
| Debt | €15k |
| of which ≤ 1y | €15k |
| of which > 1y | - |
| Working capital | €92k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 7.21 |
| Quick ratio | 7.21 |
| Working capital ratio | 77.3% |
| Solvency | 87.6% |
| Debt / equity | 0.14 |
| Long-term debt ratio | - |
| Interest coverage | 71.10 |
| Gross margin | - |
| Net margin | - |
| ROA | 97.4% |
| ROE | 111.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €119k |
| Fixed assets | 21/28 | €12k |
| Tangible fixed assets | 22/27 | €12k |
| Current assets | 29/58 | €107k |
| Investments | 50/53 | €21k |
| Cash & bank | 54/58 | €77k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €119k |
| Equity | 10/15 | €105k |
| Contributions / capital | 10/11 | €6k |
| Accumulated profits (losses) | 14 | €99k |
| Amounts payable | 17/49 | €15k |
| Amounts payable within one year | 42/48 | €15k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €149k |
| Operating result | 9901 | €147k |
| Financial income | 75 | €381 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €145k |
| Income taxes | 67/77 | €29k |
| Net result for the period | 9904 | €116k |
| Result to be appropriated | 9905 | €116k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 14-06-2023 |
| Status | Active |
| Postal code | 3020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24111E0711/00A000 | Flanders | 4,158 m² | 1 · 66 m² | 0.1 m |
| 24033F0515/00K000 | Flanders | 1,728 m² | 1 · 326 m² | 9.5 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-10-2024 De Clerck Ivo appointed as non-statutory director
- De Clerck Ivo, Niet-statutair bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "niet_statutaire_bestuurder",
"person": {
"rrn": "93.0718-285-13",
"name": "De Clerck Ivo",
"address": "Marcel Vanbellingenstraat 4 te 3020 Veltem-Beisem",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": "2024-01-01",
"evidence_quote": "Ondergetekende, Delsupehe Anne-Marie, niet-statutaire bestuurder van de bv AMD Pathology, beslist om de heer De Clerck Ivo, NN 93.0718-285-13, wonende Marcel Vanbellingenstraat 4 te 3020 Veltem-Beisem aan te stellen als niet-statutaire bestuurder met ingang van 01 januari 2024.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "future"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2024-10-11",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-10-11",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0802.720.233",
"name_full": "AMD Pathology",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Anne-Marie Delsupehe",
"org_rep_person_name": null,
"person_role_at_subject": "Niet-statutaire bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | AMD Pathology |